These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34875506)

  • 21. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.
    Brecht WJ; Harris FM; Chang S; Tesseur I; Yu GQ; Xu Q; Dee Fish J; Wyss-Coray T; Buttini M; Mucke L; Mahley RW; Huang Y
    J Neurosci; 2004 Mar; 24(10):2527-34. PubMed ID: 15014128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.
    Agarwal R; Tripathi CB
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels.
    Riddell DR; Zhou H; Atchison K; Warwick HK; Atkinson PJ; Jefferson J; Xu L; Aschmies S; Kirksey Y; Hu Y; Wagner E; Parratt A; Xu J; Li Z; Zaleska MM; Jacobsen JS; Pangalos MN; Reinhart PH
    J Neurosci; 2008 Nov; 28(45):11445-53. PubMed ID: 18987181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E4 decreases whereas apolipoprotein E3 increases the level of secreted amyloid precursor protein after closed head injury.
    Ezra Y; Oron L; Moskovich L; Roses AD; Beni SM; Shohami E; Michaelson DM
    Neuroscience; 2003; 121(2):315-25. PubMed ID: 14521991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human apoE isoforms differentially regulate brain amyloid-β peptide clearance.
    Castellano JM; Kim J; Stewart FR; Jiang H; DeMattos RB; Patterson BW; Fagan AM; Morris JC; Mawuenyega KG; Cruchaga C; Goate AM; Bales KR; Paul SM; Bateman RJ; Holtzman DM
    Sci Transl Med; 2011 Jun; 3(89):89ra57. PubMed ID: 21715678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid precursor protein mediates monocyte adhesion in AD tissue and apoE(-)/(-) mice.
    Austin SA; Combs CK
    Neurobiol Aging; 2010 Nov; 31(11):1854-66. PubMed ID: 19058878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid-β42 alters apolipoprotein E solubility in brains of mice with five familial AD mutations.
    Youmans KL; Leung S; Zhang J; Maus E; Baysac K; Bu G; Vassar R; Yu C; LaDu MJ
    J Neurosci Methods; 2011 Mar; 196(1):51-9. PubMed ID: 21219931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of oxidative stress on amyloid precursor protein processing in cells engaged in beta-amyloidosis is related to apolipoprotein E genotype.
    Mazur-Kolecka B; Kowal D; Sukontasup T; Dickson D; Frackowiak J
    Acta Neuropathol; 2004 Oct; 108(4):287-94. PubMed ID: 15221339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model.
    Huynh TV; Wang C; Tran AC; Tabor GT; Mahan TE; Francis CM; Finn MB; Spellman R; Manis M; Tanzi RE; Ulrich JD; Holtzman DM
    Mol Neurodegener; 2019 Oct; 14(1):37. PubMed ID: 31623648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the etiology of Alzheimer disease using molecular genetics.
    Lendon CL; Ashall F; Goate AM
    JAMA; 1997 Mar; 277(10):825-31. PubMed ID: 9052714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's Disease.
    Shackleton B; Crawford F; Bachmeier C
    Curr Alzheimer Res; 2017; 14(6):578-585. PubMed ID: 28164773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
    Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
    J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.
    Kim HC; Kim DK; Choi IJ; Kang KH; Yi SD; Park J; Park YN
    Psychiatry Clin Neurosci; 2001 Apr; 55(2):115-20. PubMed ID: 11285089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APOE and AβPP gene variation in cortical and cerebrovascular amyloid-β pathology and Alzheimer's disease: a population-based analysis.
    Peuralinna T; Tanskanen M; Mäkelä M; Polvikoski T; Paetau A; Kalimo H; Sulkava R; Hardy J; Lai SL; Arepalli S; Hernandez D; Traynor BJ; Singleton A; Tienari PJ; Myllykangas L
    J Alzheimers Dis; 2011; 26(2):377-85. PubMed ID: 21654062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients.
    Olsson A; Höglund K; Sjögren M; Andreasen N; Minthon L; Lannfelt L; Buerger K; Möller HJ; Hampel H; Davidsson P; Blennow K
    Exp Neurol; 2003 Sep; 183(1):74-80. PubMed ID: 12957490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.
    Fitz NF; Tapias V; Cronican AA; Castranio EL; Saleem M; Carter AY; Lefterova M; Lefterov I; Koldamova R
    Brain; 2015 Dec; 138(Pt 12):3699-715. PubMed ID: 26510953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
    Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
    J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of APP and APLP2 mRNA in APOE genotyped Alzheimer's disease brains.
    Johnston JA; Norgren S; Ravid R; Wasco W; Winblad B; Lannfelt L; Cowburn RF
    Brain Res Mol Brain Res; 1996 Dec; 43(1-2):85-95. PubMed ID: 9037522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E genotype, Alzheimer's pathologies and related gene expression in the aged population.
    Oyama F; Shimada H; Oyama R; Ihara Y
    Brain Res Mol Brain Res; 1995 Mar; 29(1):92-8. PubMed ID: 7770005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.